Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptosomal-associated protein 25 kDa (SNAP‑25) is a presynaptic plasma membrane–associated t-SNARE/Q-SNARE protein encoded by the *SNAP25* gene on chromosome 20p12.2 in humans. It is a core component of the SNARE complex that mediates synaptic vesicle docking and Ca²⁺‑triggered fusion with the presynaptic membrane during neurotransmitter release. The SNARE complex consists of four α-helices—two contributed by SNAP‑25 and one each from syntaxin‑1 and synaptobrevin/VAMP2—which assemble into a coiled-coil structure to drive membrane fusion. SNAP‑25 is palmitoylated for membrane association but lacks a transmembrane domain.\n\nTwo main isoforms exist due to alternative splicing—SNAP‑25a (embryonic) and SNAP‑25b (postnatal/adult)—with distinct roles in secretion dynamics. Genetic ablation or proteolytic cleavage by botulinum toxins abolishes fast synaptic transmission. Beyond its central role in exocytosis at neuronal synapses, SNAP‑25 also influences postsynaptic receptor trafficking, dendritic spine morphology/density, neuronal development/plasticity, metabolism regulation outside the nervous system, and has been implicated in several neurological/psychiatric diseases including ADHD, schizophrenia, bipolar disorder, epilepsy, Alzheimer’s disease as well as learning disabilities.
Cleavage/inhibition by botulinum neurotoxins blocks SNARE complex formation and exocytosis of neurotransmitters leading to neuroparalysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptosomal-associated protein 25 kDa (SNAP-25).